Skip to main content
Top
Published in: Gastric Cancer 3/2024

Open Access 22-03-2024 | Metastasis | Correction

Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis

Authors: Yushuai Mi, Quanhui Li, Bingtian Liu, Dehai Wang, Ziping Liu, Tianshi Wang, Yuan Wang, Yifeng Zang, Yan Zhou, Yugang Wen, Yinlu Ding

Published in: Gastric Cancer | Issue 3/2024

Login to get access

Excerpt

Correction: Gastric Cancer (2022) 26:69–81 https://doi.org/10.1007/s10120-022-01340-7
Metadata
Title
Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis
Authors
Yushuai Mi
Quanhui Li
Bingtian Liu
Dehai Wang
Ziping Liu
Tianshi Wang
Yuan Wang
Yifeng Zang
Yan Zhou
Yugang Wen
Yinlu Ding
Publication date
22-03-2024
Publisher
Springer Nature Singapore
Published in
Gastric Cancer / Issue 3/2024
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-024-01490-w

Other articles of this Issue 3/2024

Gastric Cancer 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine